Related Experiment Video
Updated: Aug 2, 2025

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Gene Therapy for Inborn Errors of Immunity.
Tiphaine Arlabosse1, Claire Booth2, Fabio Candotti3
1Pediatric Immuno-Rheumatology of Western Switzerland, Division of Pediatrics, Women-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland.
Gene therapy (GT) offers an alternative to stem cell transplants for severe inborn errors of immunity (IEIs). Advances in gene editing expand treatment options, though challenges remain for rare diseases.
Area of Science:
- Immunology
- Genetics
- Biotechnology
Background:
- Gene therapy (GT) emerged in the 1990s as an alternative to hematopoietic stem cell transplantation for severe inborn errors of immunity (IEIs).
- GT using autologous hematopoietic stem cells offers advantages like eliminating donor searches and graft-versus-host disease risks.
Conclusions:
- Gene therapy has shown promise for treating inborn errors of immunity, with ongoing advancements.
- Challenges persist, particularly concerning the safety of gene transfer tools and the economic viability for rare disease treatments.
More Related Videos
Related Concept Videos
Gene Therapy
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Microorganisms in Medicine and Therapeutics
Inborn Errors of Metabolism
Tumor Immunotherapy
Cell-mediated Immune Responses

